SeaStar Medical Holding Co. (NASDAQ:ICU) Sees Significant Growth in Short Interest

SeaStar Medical Holding Co. (NASDAQ:ICU) was the target of a large increase in short interest in September. As of September 30th, there was short interest totalling 212,100 shares, an increase of 79.0% from the September 15th total of 118,500 shares. Currently, 5.5% of the shares of the stock are sold short. Based on an average daily trading volume, of 134,700 shares, the short-interest ratio is currently 1.6 days.

SeaStar Medical Stock Up 2.8 %

Shares of NASDAQ ICU opened at $4.06 on Monday. The firm’s 50-day simple moving average is $5.33 and its 200 day simple moving average is $8.48. The company has a market cap of $13.08 million, a price-to-earnings ratio of -0.16 and a beta of -1.14. SeaStar Medical has a 12-month low of $3.25 and a 12-month high of $42.92.

SeaStar Medical (NASDAQ:ICU) last issued its quarterly earnings results on Tuesday, August 13th. The company reported ($1.03) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.41) by $0.38.

About SeaStar Medical

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome.